Log In
BCIQ
Print this Print this
 

Zarontin, ethosuximide

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOral formulation of ethosuximide
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationEpilepsy
Indication DetailsControl absence epilepsy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today